Obeticholic acid (OCA) improves non-invasive markers of fibrosis in patients with non-alcoholic steatohepatitis (NASH): a secondary analysis of the phase 3 Regenerate study. (February 2020)

• Record Type: Journal Article
• Authors: Anstee, Q.M.; Harrison, S.; Sanyal, Arun J.; Ratziu, V.; Rinella, M.; Younossi, Z.Y.; Boursier, J.; Francque, S.; Geerts, A.; Petta, S.; Bugianesi, E-; Romero-Gomez, M.; Schattenberg, J.M.; Sarkar, S.; Bonacini, M.; Yataco, M.; Porayko, M.; Siddique, A.; Dufour, J.; Ferro, T.; A.Venugopal, ; Zaru, L.; Shringarpure, R.; MacConell, L.; Goodman, Z.; Loomba, R.
• Is Part Of: Digestive and liver disease. Volume 52(2020)Supplement 1
• Page Start: e41
• Page End: e42
• Publication Date: 2020-02
• Subjects: Digestive organs -- Diseases -- Periodicals; Liver -- Diseases -- Periodicals; 616.33005
• DOI: 10.1016/j.dld.2019.12.136
• Languages: English
• ISSNs: 1590-8658